BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 11402436)

  • 21. [Specific estrogen receptor modulators (SERMs)].
    Trémollières F; Lopes P
    Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.
    Dhingra K
    Cancer Invest; 2001; 19(6):649-59. PubMed ID: 11486708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture.
    Jordan VC
    Ann N Y Acad Sci; 2001 Dec; 952():60-72. PubMed ID: 11795444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
    de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
    Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The endocrine prevention of breast cancer.
    Howell A
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):615-23. PubMed ID: 18971122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprevention of breast cancer in the older patient.
    Minton SE
    Hematol Oncol Clin North Am; 2000 Feb; 14(1):113-30. PubMed ID: 10680075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action.
    Sporn MB; Dowsett SA; Mershon J; Bryant HU
    Clin Ther; 2004 Jun; 26(6):830-40. PubMed ID: 15262454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects.
    Muchmore DB
    Oncologist; 2000; 5(5):388-92. PubMed ID: 11040275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention of breast cancer: implications for postmenopausal women.
    Fabian CJ; Kimler BF
    Drugs Aging; 2002; 19(1):43-78. PubMed ID: 11929326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exemestane for primary prevention of breast cancer in postmenopausal women.
    Zhang Y; Simondsen K; Kolesar JM
    Am J Health Syst Pharm; 2012 Aug; 69(16):1384-8. PubMed ID: 22855103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV; Thomas S
    J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
    Johnston SR
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on raloxifene to prevent endometrial-breast cancer.
    Goldstein SR
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S54-6. PubMed ID: 11056320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of breast cancer using SERMs and aromatase inhibitors.
    Strassmer-Weippl K; Goss PE
    J Mammary Gland Biol Neoplasia; 2003 Jan; 8(1):5-18. PubMed ID: 14587860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for the gynecologist to prescribe in the prevention of breast cancer: current status and future trends.
    Goldstein SR
    Am J Obstet Gynecol; 2000 May; 182(5):1121-6. PubMed ID: 10819845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs).
    Lo SS; Vogel VG
    Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):97-111. PubMed ID: 14687600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiestrogens: clinical applications of pharmacology.
    Jordan VC
    J Soc Gynecol Investig; 2000; 7(1 Suppl):S47-8. PubMed ID: 10732329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators.
    Pinkerton JV; Conner EA
    Climacteric; 2019 Apr; 22(2):140-147. PubMed ID: 30895900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts in breast cancer chemoprevention.
    Chlebowski RT
    Pol Arch Med Wewn; 2014; 124(4):191-9. PubMed ID: 24618912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.